You have 9 free searches left this month | for more free features.

Condition

Cancer (1)

Langerhans Cell Histiocytosis (1)

Multiple Myeloma (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

Sponsor

GlaxoSmithKline (2)

Novartis (1)

Collaborator

Intervention

gsk2110183 (3)

bortezomib (1)

dexamethasone (1)

gsk1120212 (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

gsk2110183

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Langerhans Cell Histiocytosis Trial in United States (GSK2110183)

Completed

Langerhans Cell Histiocytosis

GSK2110183

Baltimore, Maryland
+4 more

Sep 3, 2020

Multiple Myeloma Trial in Worldwide (GSK2110183, Bortezomib, Dexamethasone)

Completed

Multiple Myeloma

GSK2110183
+2 more

Scottsdale, Arizona
+12 more

Aug 6, 2018

Cancer Trial in Dallas, San Antonio (GSK1120212, GSK2110183)

Completed

Cancer

GSK1120212
GSK2110183

Dallas, Texas
+1 more

Nov 8, 2017